S. 5130

119 S5130 IS: Human Dignity and Emerging Technologies Act
 U.S. Senate
 2026-07-23
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 II  119th CONGRESS  2d Session  S. 5130  IN THE SENATE OF THE UNITED STATES   July 23, 2026   Mr. Cruz  (for himself and  Mr. Warnock ) introduced the following bill; which was read twice and referred to the  Committee on Commerce, Science, and Transportation    A BILL
To establish the United States Commission on Human Dignity, and for other purposes.
1.
Short title
This Act may be cited as the   Human Dignity and Emerging Technologies Act  .
2.
Definitions
In this Act:
(1)
Appropriate congressional committees
The term  appropriate congressional committees  means—
(A)
the Committee on Commerce, Science, and Transportation of the Senate; and
(B)
the Committee on Science, Space, and Technology of the House of Representatives.
(2)
Artificial intelligence
The term  artificial intelligence  has the meaning given the term in section 5002 of the National Artificial Intelligence Initiative Act of 2020 ( 15 U.S.C. 9401 ).
(3)
Commission
The term  Commission  means the United States Commission on Human Dignity established by section 3.
3.
Establishment
There is established within the legislative branch of the Federal Government an independent, advisory commission to be known as the  United States Commission on Human Dignity .
4.
Purpose
The purpose of the Commission is to provide independent advice to the Federal Government, including Congress, on the ethical and policy dimensions of developments in emerging technologies such as artificial intelligence to inform Federal policy. In carrying out this purpose, the Commission shall recognize the geopolitical dimensions of emerging technologies, including the challenge posed by foreign state actors whose documented use of such technologies threatens human dignity.
5.
Composition and appointment
(a)
Membership
(1)
Appointment
The Commission shall be composed of 17 members, of whom—
(A)
5 members shall be appointed by the President;
(B)
4 members shall be appointed by the majority leader of the Senate, 2 of whom shall be chosen on the recommendation of the minority leader of the Senate;
(C)
4 members shall be appointed by the Speaker of the House of Representatives, 2 of whom shall be chosen on the recommendation of the minority leader of the House of Representatives; and
(D)
4 members shall be appointed by the appropriate congressional committees, with 2 members appointed by the respective chairs and 2 members appointed by the respective ranking members of each committee.
(2)
Qualifications
Members appointed under paragraph (1) shall be selected only from among those who have demonstrated expertise and integrity in the fields of philosophy, ethics, civil rights, religion, social sciences, science, technology, medicine, or law.
(3)
Appointment deadline
Members shall be appointed to the Commission under paragraph (1) not later than 180 days after the date of the enactment of this Act. If 1 or more appointments under paragraph (1) is not made by the appointment date, such position shall remain vacant until filled in the same manner in which the original appointment was required to be made.
(b)
Terms
Members of the Commission shall serve 5-year terms, except that a member of the Commission may continue to serve after the expiration of the term of such member until a successor is appointed.
(c)
Removal
A member of the Commission may only be removed from the Commission for cause.
(d)
Chairman; Vice Chairman
The Commission shall, by majority vote, select a Chairman and Vice Chairman from among its members to serve 2-year terms in those offices. Neither office shall control the budget of the Commission independently of a vote of the members of the Commission.
(e)
Staff
The Chairman, in consultation with the Commission, shall appoint an Executive Director and such professional staff as are necessary to carry out the duties of the Commission, subject to the approval of the appropriate congressional committees.
(f)
Space for use of Commission
Not later than 180 days after the date of the enactment of this Act, the Administrator of General Services, in consultation with the Commission, shall identify and make available suitable excess space within the Federal space inventory to house the operations of the Commission. If the Administrator is not able to make such suitable excess space available within such 180-day period, the Commission may lease space to the extent the funds are available.
(g)
Initial meeting
The Commission shall meet and begin the operations of the Commission as soon as practicable.
(h)
Quorum
After its initial meeting, the Commission shall meet upon the call of the Chairman or a majority of the members of the Commission. Nine members of the Commission shall constitute a quorum.
(i)
Vacancies
Any vacancy in the Commission shall not affect its powers but shall be filled in the same manner in which the original appointment was made.
6.
Responsibilities and duties
(a)
Responsibilities
The Commission shall—
(1)
defend the inherent dignity of the human person understood as unique, embodied, and endowed with a rational and moral nature, without regard to capability or condition, within Federal science and technology policy; and
(2)
cultivate humility in Federal science and technology policy regarding technological mastery over human nature amid geopolitical competition.
(b)
Duties
The Commission shall carry out its responsibilities described in subsection (a) by carrying out the following duties:
(1)
Creating and updating materials, such as statements and principles to inform Federal science and technology policy.
(2)
Undertaking ongoing inquiry into the bioethical implications of the following developments in science and technology:
(A)
Robotics.
(B)
Artificial intelligence.
(C)
Biotechnologies.
(D)
Neurotechnologies.
(E)
Emerging clinical technologies.
(3)
Monitoring Federal science and technology programs, supported research, regulatory proposals, and emerging scientific and technological developments for threats to the inherent dignity of the human person.
(4)
Holding public hearings and receiving testimony from philosophers, ethicists, religious leaders, social scientists, scientists, technologists, medical professionals, legal scholars, and affected members of the public on Federal science and technology policy.
(5)
Annually issuing a report to the President and appropriate congressional committees with findings, policy options, and recommendations, with the opportunity for individual members of the Commission to offer dissenting views, to inform how Federal science and technology policy should align with the Commission’s responsibilities under subsection (a).
(6)
Producing additional targeted reports or advisory opinions, as warranted, in line with the responsibilities set forth in subsection (a).
7.
Oversight and ethics
(a)
Congressional input and oversight
(1)
Evaluation of programs and policies
Upon the request of an appropriate congressional committee, the Commission shall, to the extent practicable, evaluate a Federal science and technology program or policy that is in effect.
(2)
Availability of information and documents
The Commission shall make available for inspection any information and documents requested by an appropriate congressional committee and respond to any requests to provide testimony before an appropriate congressional committee.
(b)
Information from Federal agencies
On request by the Chairman or by a majority vote of the Commission, the head of a Federal agency shall furnish information to the Commission.
(c)
Limitation on authority
The Commission shall be advisory only. Nothing in this Act shall be construed to authorize the Commission to issue regulations, compel action, adjudicate rights, enforce law, or otherwise regulate any private person.
(d)
Conflicts of interest
The Commission shall adopt, and make publicly available, a written conflict-of-interest policy for its members and staff. The policy shall establish procedures for the disclosure, review, recusal, and resolution of actual or apparent conflicts of interest. It shall be consistent with Federal ethics laws and with the ethics rules of the Senate and the House of Representatives, as applicable.
8.
Authorization of appropriations
There is authorized to be appropriated to the Commission $2,000,000 for each of fiscal years 2027 through 2031 to carry out the duties of the Commission.
9.
Termination of authority
The Commission shall terminate on October 1, 2032.